CHRU Besancon

Montbéliard 25 200

0 studies enrolling now · 1 studies all time

What they study most

Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements

Studies at this site

• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early